Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice

Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice

by Peter Buckley (Editor), John L. Waddington (Editor)

Synopsis

This authoritative reference draws upon, and combines the similarities and differences between European and American practices in the diagnosis and treatment of mood disorders and schizophrenia to provide an international approach to drug therapies. By including the most up-to-date knowledge, best practices, and clinical pearls from each continent, the editors and the 48 international expert contributors have ensured that this is a critical resource for clinicians prescribing for their patients.



The first two sections address the use of a variety of antipsychotic medications for the treatment of schizophrenia, and the clinical use of antidepressant medications and mood stabilizers for depression and mania. The authors discuss their experiences of treatment using some of the most recently available drugs and others which are currently under development. The key issues of concern to the clinician, and broader topics of clinical psychopharmacology, are addressed in the final section which covers underlying principles and offers practical advice.

$6.48

Save:$46.47 (88%)

Quantity

2 in stock

More Information

Format: Paperback
Pages: 368
Edition: 1
Publisher: CRC Press
Published: 05 Jun 2000

ISBN 10: 0750640960
ISBN 13: 9780750640961

Media Reviews
The editors and authors have efficiently and readably compiled information derived from extraordinarily high levels of scientific and clinical knowledge and experience, to provide essential, useful and reliable information on specific topics pertinent to the informed treatment of psychiatrically ill persons and psychotic and major affective disorders.
From the foreword by Ross J Baldessarini

Advances in psychopharmacology, neurosciences, and information systems place considerable burden on authors of books describing 'new' therapies, as they face the risk of being obsolete before the printers ink dries. This book boldly (and admirably) takes on the challenge by condensing a wealth of material from numerous published studies whilst applying clinical experience. (It has) earned its place amongst reference bibliography for clinicians, lecturers, students, researchers and psychopharmacologists alike...an invaluable resource for those difficult situations.
International Review of Psychiatry